Luisa M. Solis Soto

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

28h-index3.3kcitations258works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(55), Lung Cancer Treatments and Mutations(36), RNA modifications and cancer(31), Lung Cancer Research Studies(27), Immune Cell Function and Interaction(24)

Publications258 total

CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level
2025· 1 citedOpen Access
Abstract A027: Mode of presentation and symptoms at diagnosis of early- and late-onset colorectal cancer: a large retrospective AI-powered analysis
Clinical Cancer Research·2025
Abstract C013: Spatial immune profiling of early- and late-onset colorectal cancer
Clinical Cancer Research·2025
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
UNC Libraries·2025Open Access
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Cancers·2025Open Access
Smart spatial omics (S2-omics) optimizes region of interest selection to capture molecular heterogeneity in diverse tissues
Nature Cell Biology·2025· 3 citedOpen Access
STAT3 Inhibition to Treat Ulcerative Colitis-Associated Colorectal Cancer
International Journal of Molecular Sciences·2025Open Access
Intermediate filaments promote glioblastoma cell invasion by controlling nuclear deformations and mechanosensitive expression of MMP14
Cell Reports·2025· 2 citedOpen Access
191 Tumor microenvironment changes after treatment with avelumab combinations in patients with advanced solid tumors
Regular and Young Investigator Award Abstracts·2025Open Access
1246 A single-cell atlas of ovarian cancer reveals tumor microenvironmental heterogeneity and cancer cell plasticity in response to therapies
Regular and Young Investigator Award Abstracts·2025Open Access
DNAR-08. Phase I Trial of Peposertib (DNA-PK inhibitor) Plus Radiation in Newly Diagnosed MGMT-Unmethylated Glioblastoma, Updated Clinical, Radiographic, and Biomarker Outcomes
Neuro-Oncology·2025· 1 citedOpen Access
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Potential Marker of HPV-Independent Disease
Cancers·2025Open Access
YAP1 defines an emergent, plastic population of relapsed small cell lung cancer
2025Open Access
Designing smart spatial omics experiments with S2-omics v1
2025Open Access
Designing smart spatial omics experiments with S2-omics v2
2025· 1 citedOpen Access
Smart spatial omics (S2-omics) optimizes region-of-interest selection to capture molecular heterogeneity in diverse tissues v2
2025Open Access
Supplementary Table S4 from Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities
2025Open Access
Supplementary Figure S1 from Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities
2025Open Access
P1.11.70 Immune Cell Infiltration and Spatial Associations in the Tumor Microenvironment Following Dual ICI or ICI-Chemotherapy
Journal of Thoracic Oncology·2025
Supplementary Table S3 from Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities
2025Open Access
page 1 of 13Next →

Frequent Co-authors

Ignacio I. Wistuba(30), Edwin R. Parra(15), Cara Haymaker(11), Carmen Behrens(10), Junya Fujimoto(10), Don L. Gibbons(9), John V. Heymach(9), J. Jack Lee(8), P. Andrew Futreal(8), Lauren A. Byers(7), Humam Kadara(7), Alejandra G. Serrano(7), Linghua Wang(7), Jing Wang(6), Anirban Maitra(6), Lixia Diao(5), Alexander J. Lazar(5), Sharia Hernandez(5), Jennifer A. Wargo(4), Carl M. Gay(4)